Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies

Blood (2019) 134 (Supplement_1): 4092.

https://doi.org/10.1182/blood-2019-123083

Published: 2019

Journal Articles

Dynamic and Time-to-Event Analyses Demonstrate Marked Reduction in Transfusion Requirements for Janus Kinase Inhibitor-Naïve Myelofibrosis Patients Treated with Momelotinib Compared Head to Head with Ruxolitinib

Ruben A Mesa, MD, John Catalano, MBBS, FRACP, FRCPA, Francisco Cervantes, MD, Timothy Devos, MD PhD, Jason Gotlib, MD MS, Jean-Jacques Kiladjian, MD PhD, Donal P. McLornan, MB, BCh (Hons), MRCP, PhD FRCPath, Kazuya Shimoda, MD PhD, Elisabeth Coart, PhD, Koenraad D'Hollander, MD MSC, Rafe Donahue, PhD, Mark M Kowalski, MD PhD

Blood (2019) 134 (Supplement_1): 1663.

https://doi.org/10.1182/blood-2019-122506

Published: 2019

Journal Articles

Targeting CD38 high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells

Emma Nolan, BSc, Arwen Stikvoort, PhD, Mark Gurney, MD, Nutsa Burduli, BSc, Lucy Kirkham-McCarthy, MSc, John Daly, MSc, Niels W. C. J. Van De Donk, Tuna Mutis, MD PhD, Subhashis Sarkar, PhD, Michael E O'Dwyer, MD

Blood (2019) 134 (Supplement_1): 5536.

https://doi.org/10.1182/blood-2019-128605

Published: 2019

Journal Articles

The Role of Image Surveillance in Patients with Diffuse Large B-Cell Lymphoma: A Single-Center Validation Study

Takanori Fukuta, MD, Noriko Nishimura, MD PhD, Yuko Shirouchi, MD, Anna Nishihara, MD, Norihito Inoue, MD, Hideki Uryu, MD, Yoshiharu Kusano, MD, Yuko Mishima, MD PhD, Naoko Tsuyama, MD PhD, Kengo Takeuchi, MD PhD, Masahiro Yokoyama, MD, Yasuhito Terui, MD PhD

Blood (2018) 132 (Supplement 1): 2989.

https://doi.org/10.1182/blood-2018-99-113984

Published: 2018

Journal Articles

CD33/CD3-Bispecific T-Cell Engaging (BiTE®) Antibody Constructs Efficiently Target Monocytic CD14 + hla-DR low IDO + aml-MDSCs

Dimitrios Mougiakakos, Domenica Saul, Martina Braun, Dr., Sehmus Tohumeken, Roman Kischel, MD, Lutteropp Michael, Dr., Cedric E. Dos Santos, Regina Jitschin, PhDMD, Andreas Mackensen, MD

Blood (2017) 130 (Supplement 1): 1363.

https://doi.org/10.1182/blood.V130.Suppl_1.1363.1363

Published: 2017

Journal Articles

Whole Genome Amplification and Exome Sequencing at the Single Cell Level - a Way to Address Clonal Heterogeneity and Very Sparse Clinical Material

Peter Hokland, MD DMedSc, Professor, Anita T Simonsen, MSc, PhDStud., Marcus Celik Hansen, MSc, Biomedical Engineer, Johnny Juhl Hindkjær, MSc, PhD, Anni Aggerholm, PhD MSc

Blood (2016) 128 (22): 1671.

https://doi.org/10.1182/blood.V128.22.1671.1671

Published: 2016

Journal Articles

Probiotic Enteric Regimen for Easing the Complications of Transplant

Elan Gorshein, DO, Susan Ambrosy, Shanna Budney, Juliana Vivas, Jacqueline Manago, Mary Kate McGrath, Anne Tyno, Roger Strair, MD PhD

Blood (2014) 124 (21): 5877.

https://doi.org/10.1182/blood.V124.21.5877.5877

Published: 2014

Journal Articles

Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel Agents

Shaji K. Kumar, MD, Angela Dispenzieri, MD, Morie A Gertz, Martha Q Lacy, MD, John A Lust, MD, PhD, Suzanne R Hayman, MD, Francis K Buadi, M.D., David Dingli, M.D., Ph.D., Steven R Zeldenrust, MD, PhD, Stephen Russell, MD, PhD, Prashant Kapoor, MD, Yi Lin, MD, PhD, Lisa Hwa, RN, CNP, Dirk Larson, Colin L. Colby, Joanne T Benson, Robert A. Kyle, MD, S. Vincent Rajkumar, MD

Blood (2012) 120 (21): 3972.

https://doi.org/10.1182/blood.V120.21.3972.3972

Published: 2012

Journal Articles

New GMP-Grade, Xeno-Component Free Medium for the Activation and Expansion of T Cells

Mario Assenmacher, Nadine Mockel-Tenbrinck, Alexander Scheffold, Georg Rauser, Hermann Bohnenkamp, Jürgen Schmitz, Uwe Odenthal, Bergendahl Veit, Ulrike Kolrep, Melanie Fahrendorff

Blood (2011) 118 (21): 4316.

https://doi.org/10.1182/blood.V118.21.4316.4316

Published: 2011

Journal Articles

Pretransplant Characteristics Could Predict Full Donor Chimerism on Day +90 and Day +180 and Outcomes in Reduced Intensity Alemtuzumab Conditioning Allogeneic Transplantation Can Be Influenced by Chimeric Status

Emmanouil Nikolousis, Charles F. Craddock, BM, MRCP, MRCPath, Shankaranarayana Paneesha, MD, Sudhir Tauro, Prem Mahendra, II, Mark Cook, Fiona Clark, Richard Lovell, Sridhar Chaganti, Donald Milligan, MD, MBChB, Dominique Mcmullan, Mike Griffiths, Stephen P Robinson, MD

Blood (2008) 112 (11): 4409.

https://doi.org/10.1182/blood.V112.11.4409.4409

Published: 2008

Journal Articles

Sensitive and Simple Methodologies for Measuring of Red Blood Cell (RBC) Electrical Properties and Cell Aggregation.

Heloise Pockel Fernandes, Bsc, Adriana Fontes, PhD, André A Thomaz, Msc, Luiz C Barbosa, PhD, Vagner Castro, MD, PhD, Carlos Lenz Cesar, PhD, Maria Lourdes Barjas-Castro, MD, PhD

Blood (2008) 112 (11): 998.

https://doi.org/10.1182/blood.V112.11.998.998

Published: 2008

Journal Articles

Prior Treatment Relates More Strongly to Richter’s Transformation Than ZAP-70, CD38, IgV H Gene Mutation Status, and Cytogenetic Abnormalities: Findings of an Observational Cohort Study of 962 Patients with CLL.

Kami Maddocks-Christianson, Clive S. Zent, MD, Susan Slager, PhD, Susan Schwager, Megan Reinalda, Timothy G. Call, MD, Deborah Bowen, MD, James Hoyer, MD, Diane F. Jelinek, PhD, Neil E. Kay, MD, Tait D. Shanafelt, MD

Blood (2006) 108 (11): 2777.

https://doi.org/10.1182/blood.V108.11.2777.2777

Published: 2006

NARROW

Potential Factors That Impact Lenalidomide/R-CHOP Efficacy in Previously Untreated Diffuse Large B-Cell Lymphoma in the ROBUST and ECOG-ACRIN 1412 Studies

Dynamic and Time-to-Event Analyses Demonstrate Marked Reduction in Transfusion Requirements for Janus Kinase Inhibitor-Naïve Myelofibrosis Patients Treated with Momelotinib Compared Head to Head with Ruxolitinib

Targeting CD38 high Acute Myeloid Leukaemia with "Affinity Optimized" Chimeric Antigen Receptor and Membrane Bound TRAIL Expressing Natural Killer Cells

The Role of Image Surveillance in Patients with Diffuse Large B-Cell Lymphoma: A Single-Center Validation Study

CD33/CD3-Bispecific T-Cell Engaging (BiTE®) Antibody Constructs Efficiently Target Monocytic CD14 + hla-DR low IDO + aml-MDSCs

Whole Genome Amplification and Exome Sequencing at the Single Cell Level - a Way to Address Clonal Heterogeneity and Very Sparse Clinical Material

Probiotic Enteric Regimen for Easing the Complications of Transplant

Continued Improvement in Survival in Multiple Myeloma and the Impact of Novel Agents

New GMP-Grade, Xeno-Component Free Medium for the Activation and Expansion of T Cells

Pretransplant Characteristics Could Predict Full Donor Chimerism on Day +90 and Day +180 and Outcomes in Reduced Intensity Alemtuzumab Conditioning Allogeneic Transplantation Can Be Influenced by Chimeric Status

Sensitive and Simple Methodologies for Measuring of Red Blood Cell (RBC) Electrical Properties and Cell Aggregation.

Prior Treatment Relates More Strongly to Richter’s Transformation Than ZAP-70, CD38, IgV H Gene Mutation Status, and Cytogenetic Abnormalities: Findings of an Observational Cohort Study of 962 Patients with CLL.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only